Related Experiment Video
Updated: Jun 11, 2026

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer
Published on: May 21, 2019
NetCF: A Network Control-based Framework to Reveal the Molecular Mechanism of Phenotype Switching in Lung Cancer
Namhee Kim1, Jongwan Kim1, Jaeog Jeon1
1Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.
Abstract:
While targeted therapies are widely used in cancer treatment with specific biomarkers, they still encounter critical challenges such as intrinsic drug resistance. Discovery of combination targets to overcome such resistance is crucial. However, due to intricate molecular regulations, identifying a combination target against targeted therapies remains problematic. To systematically tackle this problem, we present a network control strategy for identifying a core switching circuit in cell state transition through feedback analysis (NetCF). This framework identifies a combination target and unravels the underlying mechanism based on data-driven Boolean network modeling and complex network analysis. NetCF explores a core switching circuit, composed of coupled positive feedback loops, that drives a phenotype change when the identified combination target is regulated. By applying this framework to lung cancer cells, we suggest PIN1 as an effective combination target to overcome resistance to MEK inhibitor. Our framework identifies potential therapeutic interventions for cancer in the form of combination targets and their system-level mechanisms that enable them to overcome drug resistance. NetCF is available at https://github.com/namheee/NetCF.
Insights
This study introduces NetCF, a network control strategy to identify combination targets for overcoming cancer drug resistance. It suggests PIN1 as a target to combat MEK inhibitor resistance in lung cancer.
Area of Science:
- Computational Biology
- Systems Biology
- Cancer Research
Background:
- Targeted cancer therapies face challenges with intrinsic drug resistance.
- Identifying effective combination targets to overcome resistance is crucial but complex.
- Intricate molecular regulations hinder the discovery of combination targets.
Purpose of the Study:
- To present a network control strategy (NetCF) for identifying combination targets.
- To systematically tackle the problem of intrinsic drug resistance in cancer therapy.
- To unravel the underlying mechanisms of combination targets in overcoming resistance.
Main Methods:
- Utilized data-driven Boolean network modeling.
- Employed complex network analysis.
- Applied feedback analysis to identify core switching circuits in cell state transitions.
Main Results:
- Identified a core switching circuit composed of coupled positive feedback loops.
- Demonstrated that regulating the identified combination target drives phenotype changes.
- Suggested PIN1 as an effective combination target against MEK inhibitor resistance in lung cancer cells.
Conclusions:
- NetCF framework successfully identifies combination targets and their system-level mechanisms.
- This approach offers potential therapeutic interventions to overcome cancer drug resistance.
- The study provides a systematic method for discovering combination therapies.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
